Metrics to compare | 1784 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1784PeersSector | |
|---|---|---|---|---|
P/E Ratio | 69.1x | 15.3x | −0.4x | |
PEG Ratio | −1.93 | −0.29 | 0.00 | |
Price/Book | 2.7x | 1.2x | 2.6x | |
Price / LTM Sales | 2.7x | 3.6x | 3.0x | |
Upside (Analyst Target) | - | 30.8% | 58.4% | |
Fair Value Upside | Unlock | 23.5% | 8.6% | Unlock |
BIONET Corp. engages in cell therapy, regenerative medicine, medical big data, gene testing, and sales of biological and scientific information hardware and software business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells, as well as skin care products. It also provides storage and application of hematopoietic stem cells, analytical testing, clinical and preclinical research, commercialized cell-derived products, and Exosome, a cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan.